These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 21975808

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
    Sahoo J, Murthy PN, Biswal S, Manik.
    AAPS PharmSciTech; 2009; 10(1):27-33. PubMed ID: 19145487
    [Abstract] [Full Text] [Related]

  • 3. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D, Sharma R, Jain D.
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method.
    Douroumis D, Bouropoulos N, Fahr A.
    J Pharm Pharmacol; 2007 May; 59(5):645-53. PubMed ID: 17524229
    [Abstract] [Full Text] [Related]

  • 7. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J, Milovanovic S, Medarevic D, Dobricic V, Dapčević A, Ibric S.
    Int J Pharm; 2019 Jan 10; 554():190-200. PubMed ID: 30414899
    [Abstract] [Full Text] [Related]

  • 8. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T, Wan J, Xu H, Yang X.
    Eur J Pharm Sci; 2008 Aug 07; 34(4-5):274-80. PubMed ID: 18541418
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR, Jäger N, Funke A, Mürb RK, Khinast JG, Paudel A.
    Int J Pharm; 2018 Dec 20; 553(1-2):408-421. PubMed ID: 30326284
    [Abstract] [Full Text] [Related]

  • 11. Characterization and drug release investigation of amorphous drug-hydroxypropyl methylcellulose composites made via supercritical carbon dioxide assisted impregnation.
    Gong K, Rehman IU, Darr JA.
    J Pharm Biomed Anal; 2008 Dec 01; 48(4):1112-9. PubMed ID: 18922658
    [Abstract] [Full Text] [Related]

  • 12. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS.
    J Pharm Pharmacol; 2014 Feb 01; 66(2):244-55. PubMed ID: 24433425
    [Abstract] [Full Text] [Related]

  • 13. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H, Fussnegger B, Bodmeier R.
    Int J Pharm; 2010 May 10; 390(2):165-73. PubMed ID: 20132875
    [Abstract] [Full Text] [Related]

  • 14. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A, Cavallari C, Ospitali F.
    Eur J Pharm Biopharm; 2008 Sep 10; 70(1):409-20. PubMed ID: 18621516
    [Abstract] [Full Text] [Related]

  • 15. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.
    Huang BB, Liu DX, Liu K, Wu G.
    Molecules; 2019 Nov 26; 24(23):. PubMed ID: 31779169
    [Abstract] [Full Text] [Related]

  • 16. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E, Georgarakis E, Bikiaris D.
    Eur J Pharm Biopharm; 2006 Aug 26; 64(1):115-26. PubMed ID: 16675210
    [Abstract] [Full Text] [Related]

  • 17. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2010 Mar 01; 76(1):170-8. PubMed ID: 19945828
    [Abstract] [Full Text] [Related]

  • 18. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, Yong CS, Choi HG.
    Int J Pharm; 2012 Jan 17; 422(1-2):202-10. PubMed ID: 22085435
    [Abstract] [Full Text] [Related]

  • 19. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK.
    Eur J Pharm Biopharm; 2006 Oct 17; 64(2):200-5. PubMed ID: 16750355
    [Abstract] [Full Text] [Related]

  • 20. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R, Sieger P, Karmwar P.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):723-31. PubMed ID: 23684913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.